Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow.

<h4>Background</h4>The identification of clinically meaningful and predictive models of disposition kinetics for cancer therapeutics is an ongoing pursuit in drug development. In particular, the growing interest in preclinical evaluation of anti-angiogenic agents alone or in combination...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: C Andrew Boswell, Gregory Z Ferl, Eduardo E Mundo, Daniela Bumbaca, Michelle G Schweiger, Frank-Peter Theil, Paul J Fielder, Leslie A Khawli
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8e0c62148c294416800c15a181db31e7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8e0c62148c294416800c15a181db31e7
record_format dspace
spelling oai:doaj.org-article:8e0c62148c294416800c15a181db31e72021-11-18T06:57:14ZEffects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow.1932-620310.1371/journal.pone.0017874https://doaj.org/article/8e0c62148c294416800c15a181db31e72011-03-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21436893/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The identification of clinically meaningful and predictive models of disposition kinetics for cancer therapeutics is an ongoing pursuit in drug development. In particular, the growing interest in preclinical evaluation of anti-angiogenic agents alone or in combination with other drugs requires a complete understanding of the associated physiological consequences.<h4>Methodology/principal findings</h4>Technescan™ PYP™, a clinically utilized radiopharmaceutical, was used to measure tissue vascular volumes in beige nude mice that were naïve or administered a single intravenous bolus dose of a murine anti-vascular endothelial growth factor (anti-VEGF) antibody (10 mg/kg) 24 h prior to assay. Anti-VEGF had no significant effect (p>0.05) on the fractional vascular volumes of any tissues studied; these findings were further supported by single photon emission computed tomographic imaging. In addition, apart from a borderline significant increase (p = 0.048) in mean hepatic blood flow, no significant anti-VEGF-induced differences were observed (p>0.05) in two additional physiological parameters, interstitial fluid volume and the organ blood flow rate, measured using indium-111-pentetate and rubidium-86 chloride, respectively. Areas under the concentration-time curves generated by a physiologically-based pharmacokinetic model changed substantially (>25%) in several tissues when model parameters describing compartmental volumes and blood flow rates were switched from literature to our experimentally derived values. However, negligible changes in predicted tissue exposure were observed when comparing simulations based on parameters measured in naïve versus anti-VEGF-administered mice.<h4>Conclusions/significance</h4>These observations may foster an enhanced understanding of anti-VEGF effects in murine tissues and, in particular, may be useful in modeling antibody uptake alone or in combination with anti-VEGF.C Andrew BoswellGregory Z FerlEduardo E MundoDaniela BumbacaMichelle G SchweigerFrank-Peter TheilPaul J FielderLeslie A KhawliPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 3, p e17874 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
C Andrew Boswell
Gregory Z Ferl
Eduardo E Mundo
Daniela Bumbaca
Michelle G Schweiger
Frank-Peter Theil
Paul J Fielder
Leslie A Khawli
Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow.
description <h4>Background</h4>The identification of clinically meaningful and predictive models of disposition kinetics for cancer therapeutics is an ongoing pursuit in drug development. In particular, the growing interest in preclinical evaluation of anti-angiogenic agents alone or in combination with other drugs requires a complete understanding of the associated physiological consequences.<h4>Methodology/principal findings</h4>Technescan™ PYP™, a clinically utilized radiopharmaceutical, was used to measure tissue vascular volumes in beige nude mice that were naïve or administered a single intravenous bolus dose of a murine anti-vascular endothelial growth factor (anti-VEGF) antibody (10 mg/kg) 24 h prior to assay. Anti-VEGF had no significant effect (p>0.05) on the fractional vascular volumes of any tissues studied; these findings were further supported by single photon emission computed tomographic imaging. In addition, apart from a borderline significant increase (p = 0.048) in mean hepatic blood flow, no significant anti-VEGF-induced differences were observed (p>0.05) in two additional physiological parameters, interstitial fluid volume and the organ blood flow rate, measured using indium-111-pentetate and rubidium-86 chloride, respectively. Areas under the concentration-time curves generated by a physiologically-based pharmacokinetic model changed substantially (>25%) in several tissues when model parameters describing compartmental volumes and blood flow rates were switched from literature to our experimentally derived values. However, negligible changes in predicted tissue exposure were observed when comparing simulations based on parameters measured in naïve versus anti-VEGF-administered mice.<h4>Conclusions/significance</h4>These observations may foster an enhanced understanding of anti-VEGF effects in murine tissues and, in particular, may be useful in modeling antibody uptake alone or in combination with anti-VEGF.
format article
author C Andrew Boswell
Gregory Z Ferl
Eduardo E Mundo
Daniela Bumbaca
Michelle G Schweiger
Frank-Peter Theil
Paul J Fielder
Leslie A Khawli
author_facet C Andrew Boswell
Gregory Z Ferl
Eduardo E Mundo
Daniela Bumbaca
Michelle G Schweiger
Frank-Peter Theil
Paul J Fielder
Leslie A Khawli
author_sort C Andrew Boswell
title Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow.
title_short Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow.
title_full Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow.
title_fullStr Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow.
title_full_unstemmed Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow.
title_sort effects of anti-vegf on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/8e0c62148c294416800c15a181db31e7
work_keys_str_mv AT candrewboswell effectsofantivegfonpredictedantibodybiodistributionrolesofvascularvolumeinterstitialvolumeandbloodflow
AT gregoryzferl effectsofantivegfonpredictedantibodybiodistributionrolesofvascularvolumeinterstitialvolumeandbloodflow
AT eduardoemundo effectsofantivegfonpredictedantibodybiodistributionrolesofvascularvolumeinterstitialvolumeandbloodflow
AT danielabumbaca effectsofantivegfonpredictedantibodybiodistributionrolesofvascularvolumeinterstitialvolumeandbloodflow
AT michellegschweiger effectsofantivegfonpredictedantibodybiodistributionrolesofvascularvolumeinterstitialvolumeandbloodflow
AT frankpetertheil effectsofantivegfonpredictedantibodybiodistributionrolesofvascularvolumeinterstitialvolumeandbloodflow
AT pauljfielder effectsofantivegfonpredictedantibodybiodistributionrolesofvascularvolumeinterstitialvolumeandbloodflow
AT leslieakhawli effectsofantivegfonpredictedantibodybiodistributionrolesofvascularvolumeinterstitialvolumeandbloodflow
_version_ 1718424178953027584